Skip to search formSkip to main contentSkip to account menu

Metastatic Disease Clinical Trial Setting

Known as: METASTATIC 
A clinical trial or treatment setting in which the therapy of interest is used to treat metastatic disease.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Highly Cited
2017
Highly Cited
2017
Abstract Background Previous analysis of COMBI-d (NCT01584648) demonstrated improved progression-free survival (PFS) and overall… 
Highly Cited
2016
Highly Cited
2016
Cytotoxic chemotherapy is commonly used to treat advanced Merkel cell carcinoma (MCC). However, its efficacy in distant… 
Highly Cited
2014
Highly Cited
2013
Highly Cited
2013
Multiclass brain tumor classification is performed by using a diversified dataset of 428 post-contrast T1-weighted MR images from… 
Highly Cited
2012
Highly Cited
2012
PURPOSE We evaluated the feasibility of administering carboplatin as a radiosensitizer during craniospinal radiation therapy… 
Highly Cited
2001
Highly Cited
2001
Little is known about the genetic regulation of medulloblastoma dissemination, but metastatic medulloblastoma is highly… 
Highly Cited
1991
Highly Cited
1991
Undifferentiated nasopharyngeal carcinoma (UCNT) is known to be radiosensitive and chemosensitive, but the latter has never been…